(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VERSANTIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

VERSANTIS

ST13

US500000079397393

Class

9, 42, 44

Filing

79397393

Registration

7741625

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

04/03/2026

Trademark type

Combined

Nice classes

9, 42, 44

Filing date

04/19/2024

Registration date

04/01/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/01/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

33

Owner location

FR

Examiner

LAVACHE, LINDA M

Law office

L60

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "VERSANTIS" where the letter "V" is formed by a curved band and a second curved band appears above the "V".

Holders and representatives

Holders

GENFIT

Representatives

Ronald M. Kachmarik Cooper Legal Group, LLC

Technical classification

Nice Classes

Class 9Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable and recorded software for use in the management of cancermetabolic diseases and liver diseasessoftware for creating customized care plans for patientsfor managing patient datafor providing clinical decision support information and analyticsfor managing patient medicationsfor providing reporting and analytics relating to patient care; downloadable and recorded software for use in research and development of new pharmaceutical products for otherssoftware for managinganalyzing and reporting on clinical trial data; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments particularly for recordingprocessingreproducingtransmitting data; data processing equipment; downloadable electronic publications in the nature of brochuresnewslettersreportsmedical journals and medical periodicalsin the field of preventiondiagnosis and treatment of cancermetabolic diseases and liver diseases; downloadable electronic databases in the field of preventiondiagnosis and treatment of cancermetabolic diseases and liver diseases; all these goods exclusively in the field of liver and metabolic diseases.

Class 42

Pharmaceutical research being research for the discovery of new medicines; scientific researchparticularly in the medicalbiomedicalchemical field; consultation in the field of scientific research and development of therapies; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; all these services exclusively in the field of liver and metabolic diseases.

Class 44

Medical services; veterinary services; medical assistance; hospital services; consultation with respect to pharmacypharmaceutical consultation; all these services exclusively in the field of liver and metabolic diseases.

Publications

History of USPTO decisions and trademark events.

32 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

11/30/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/12/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

11/12/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/31/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/14/2025

FIMP

FINAL DISPOSITION PROCESSED

10/14/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/02/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/19/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/01/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/01/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/11/2025

PUBO

PUBLISHED FOR OPPOSITION

02/11/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/05/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/22/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/08/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/08/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/08/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/31/2024

GNFR

FINAL REFUSAL E-MAILED

12/31/2024

CNFR

FINAL REFUSAL WRITTEN

12/31/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/04/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/04/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/04/2024

RFNT

REFUSAL PROCESSED BY IB

11/30/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/14/2024

RFRR

REFUSAL PROCESSED BY MPU

11/14/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/08/2024

CNRT

NON-FINAL ACTION WRITTEN

11/07/2024

DOCK

ASSIGNED TO EXAMINER

11/01/2024

MAFR

APPLICATION FILING RECEIPT MAILED

06/14/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/14/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/13/2024

Continuous trademark protection

Get notified about every new filing that threatens VERSANTIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.